TrialRMD open2026

Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studies.

Philip J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.